Breakthrough study aims to stop devastating strokes in young sickle cell patients
NCT ID NCT04808778
Summary
This study aims to prevent strokes in young Nigerian adults with sickle cell anemia, where strokes affect 10% of patients. Researchers will measure how common strokes and silent brain injuries are in 250 participants aged 16-25, then test whether regular blood transfusions or a daily medication called hydroxyurea can prevent these complications. The goal is to develop sustainable prevention strategies for regions with limited medical resources.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aminu Kano Teaching Hospital
Kano, Nigeria
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-9000, United States
Conditions
Explore the condition pages connected to this study.